China SXT Pharmaceuticals (SXTC) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q1 2025 value amounting to $2.4 million.
- China SXT Pharmaceuticals' Accumulated Depreciation & Amortization rose 8.92% to $2.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.4 million, marking a year-over-year increase of 8.92%. This contributed to the annual value of $2.4 million for FY2025, which is 8.92% up from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Accumulated Depreciation & Amortization of $2.4 million as of Q1 2025, which was up 8.92% from $2.4 million recorded in Q1 2024.
- China SXT Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $2.4 million for Q1 2025, and its period low was $1.5 million during Q1 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $2.0 million, with a median of $1.9 million in 2023.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Accumulated Depreciation & Amortization surged by 4215.48% in 2021, and later increased by 8.92% in 2025.
- China SXT Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $1.5 million in 2021, then grew by 25.0% to $1.8 million in 2022, then grew by 5.58% to $1.9 million in 2023, then grew by 25.97% to $2.4 million in 2024, then grew by 0.09% to $2.4 million in 2025.
- Its last three reported values are $2.4 million in Q1 2025, $2.4 million for Q1 2024, and $1.9 million during Q1 2023.